We are live on ! Find out more
RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of RARX yet.

RARX Hedge Fund Activity: Q3 2020 in Review

0 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Ra Pharmaceuticals, Inc. Common Stock (RARX) for Q3 2020, worth a combined $0 — down 100% from $32K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RARX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Daiwa Securities Group, exiting entirely with an estimated $32K sold.

  • 0 institutional investors held Ra Pharmaceuticals, Inc. Common Stock (RARX) as of Q3 2020, down from 1 in Q2 2020.
  • Funds reported $0 of Ra Pharmaceuticals, Inc. Common Stock stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Ra Pharmaceuticals, Inc. Common Stock positions in Q3 2020 and 1 closed out, a net change of -1 holder.
  • The largest Ra Pharmaceuticals, Inc. Common Stock seller in Q3 2020 was Daiwa Securities Group, an estimated $32K sold.

Based on aggregated 13F filings for Q3 2020.